黄颖,黄楠,宋菊,季沈杰,王钦君.长链非编码RNA SOX9-AS1在原发性肝细胞癌中的诊断价值.[J].中南医学科学杂志.,2023,(6):916-919. |
长链非编码RNA SOX9-AS1在原发性肝细胞癌中的诊断价值 |
The diagnostic value of long non-coding RNA SOX9-AS1 in primary hepatocellular carcinoma |
投稿时间:2023-04-17 修订日期:2023-10-16 |
DOI:10.15972/j.cnki.43-1509/r.2023.06.028 |
中文关键词: HCC 长链非编码RNA SOX9-AS1 [ |
英文关键词:HCC long non-coding RNA SOX9-AS1 |
基金项目:南通市卫生健康委员会科研课题(QB2020026,QN2022059) |
|
摘要点击次数: 153 |
全文下载次数: 102 |
中文摘要: |
目的检测SOX9-AS1在原发性肝细胞癌(HCC)患者血清中的表达水平,并探讨其诊断价值。 方法选择HCC患者、肝硬化(LC)患者、慢性乙型肝炎(CHB)患者,及同期体检健康者(HC)。采用qRT-PCR检测各组血清SOX9-AS1水平。采用ROC曲线评价血清SOX9-AS1在HCC中的诊断价值。 结果HCC组、LC组、CHB组及HC组血清SOX9-AS1和AFP水平依次降低,HCC组SOX9-AS1和AFP水平最高(P<0.05)。SOX9-AS1联合AFP对HCC的诊断效能最高(P<0.05)。 结论原发性肝细胞癌患者血清SOX9-AS1水平升高,血清SOX9-AS1可作为临床辅助诊断HCC的新指标。 |
英文摘要: |
AimTo detect the expression of SOX9-AS1 in the serum of patients with hepatocellular carcinoma (HCC) and investigate its diagnostic value. MethodsHCC patients, liver cirrhosis (LC) patients, chronic hepatitis B (CHB) patients and healthy individuals (HC) were selected. The expression of SOX9-AS1 in the serum in each group was examined by qRT-PCR. The diagnostic value of SOX9-AS1 was evaluated by ROC curve. ResultsThe relative expression of SOX9-AS1 and AFP level in HCC, LC, CHB and HC were decreased in turn, with the highest level of SOX9-AS1 and AFP in HCC (P<0.05). Combining SOX9-AS1 and AFP resulted in the highest diagnostic efficiency for HCC (P<0.05). ConclusionSerum SOX9-AS1 could be a new biomarker for clinical auxiliary diagnosis of HCC. |
查看全文 查看/发表评论 下载PDF阅读器 |
关闭 |